BioMedha is a UK-based pre-clinical CRO providing in vitro biology expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process. BioMedha expertise includes:
•	HTA authorized establishment with on-site blood donor panel
•	Immunology, Oncology, Immuno-oncology, and inflammation studies
•	Target validation, assay development, screening, and MOA studies 
•	Whole blood and Immune cell functional assays
•	Flow cytometry capabilities
•	Cytokine assays and Luminex multiplexing
•	Cell imaging expertise
•	Expression studies (protein levels, mRNA levels, and surface expression)
•	Plate reader-based assays (Fluorescence, Luminesce, Absorbance, FP, FRET, BRET, Alphascreen, HTRF)
•	Functional assays (e.g. signalling pathways, bioassays)
•	GPCRs: assay development and screening
•	Protein-Protein Interactions (PPI)
•	Enzyme activity
•	Discovery Toxicology studies

We are a small but passionate team of scientists with substantial experience in the pharmaceutical and biotech industries, focused heavily on pre-clinical drug discovery biology. We serve clients in pharma, biotech, virtual companies, spin-outs, and academic institutions.

BioMedha

Org chart

Teams

Offices